EOLS
Evolus Inc
Price:  
6.74 
USD
Volume:  
1,040,089.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

EOLS Relative Valuation

-238.2%
Upside

As of 2026-06-18, the Relative Valuation of Evolus Inc (EOLS) is (9.31) USD. This relative valuation is based on P/E multiples. With the latest stock price at 6.74 USD, the upside of Evolus Inc based on Relative Valuation is -238.2%.

The range of the Relative Valuation is (5.87) - (9.31) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 8.9x - 19.2x 15.6x
Forward P/E multiples 8.8x - 14.1x 12.6x
Fair Price (5.87) - (9.31) (9.31)
Upside -187.1% - -238.1% -238.2%
6.74 USD
Stock Price
(9.31) USD
Fair Price

EOLS Relative Valuation - Historical P/E Data

Date P/E
2026-06-17 -10.22
2026-06-16 -10.05
2026-06-15 -10.24
2026-06-12 -10.21
2026-06-11 -9.87
2026-06-10 -10.19
2026-06-09 -10.16
2026-06-08 -10.13
2026-06-05 -10.11
2026-06-04 -10.01
2026-06-03 -9.14
2026-06-02 -9.36
2026-06-01 -9.89
2026-05-29 -9.95
2026-05-28 -9.96
2026-05-27 -9.37
2026-05-26 -9.48
2026-05-22 -9.24
2026-05-21 -9.78
2026-05-20 -9.99
2026-05-19 -9.75
2026-05-18 -9.96
2026-05-15 -9.86
2026-05-14 -9.98
2026-05-13 -10.19
2026-05-12 -9.86
2026-05-11 -9.58
2026-05-08 -9.64
2026-05-07 -9.69
2026-05-06 -9.58
2026-05-05 -9.66
2026-05-04 -8.46
2026-05-01 -8.08
2026-04-30 -8.17
2026-04-29 -7.86
2026-04-28 -7.99
2026-04-27 -7.92
2026-04-24 -8.04
2026-04-23 -8.05
2026-04-22 -7.87
2026-04-21 -7.48
2026-04-20 -7.70
2026-04-17 -7.11
2026-04-16 -6.87
2026-04-15 -7.02
2026-04-14 -6.73
2026-04-13 -6.57
2026-04-10 -6.48
2026-04-09 -6.43
2026-04-08 -6.20